Pharma Training

Pharmaceutical Training: 3 Guiding Principles for Success

/ Apr 13, 2017

Training pharmaceutical representatives to understand — and maximize the benefits of — software they’re using on the job is a necessary component of any pharmaceutical sales program.

Read More
Remote PV Audits & Inpsections

Remote PV Audits & Inspections

/ Mar 29, 2017

The advantages and disadvantages of remote audits and inspections – also called virtual inspections, distant inspections, paper inspections, web inspections, and telephone inspections.

Read More

The Clinical ‘Connectors’ for Escalation Services

/ Mar 22, 2017

Soniya Patel highlights the importance of medical escalation procedures during a clinical trial.

Read More
Patient Centricity

Adopting Patient Centricity at Scale: Creating Synergy for Program Success

Susan Mattson & Ed Chase explore some of the areas hindering pharma companies from becoming fully patient-centered, and how to overcome these challenges.

Read More

WeChat as IT Support Channel for Pharma in China

/ Feb 23, 2017

Jackie Gong highlights how pharma companies in China are using WeChat as an IT contact center support channel.

Read More

CURES Act of 2016 and Drug Safety

/ Feb 03, 2017

A look at the somewhat controversial law was passed in late 2016 known as The 21st Century Cures Act - and its implications for drug safety.

Read More
PMCs and PMRs

PMCs and PMRs: Some Good News

/ Jan 05, 2017

Bart Cobert looks at the recent FDA report on Post-Marketing Requirements (PMRs) and Post-Marketing Commitments (PMCs).

Read More

Using NPS to Improve the Customer Experience in Japan

/ Dec 05, 2016

A look at Net Promoter Score (NPS), and its use in the Japanese contact center industry

Read More

How Precision Medicine is Making Patient Engagement More Personal

/ Nov 29, 2016

Pharma companies continue to develop more individualized treatments. Programs to support this precision medicine approach should be tailored yet adaptive.

Read More

Timely Reporting to the FDA

/ Nov 22, 2016

Bart Cobert examines 2 recent cases of late reporting of clinical trial information to the FDA and other federal agencies.

Read More